Hochschulschrift
Charakterisierung von Osteoprotegerin (OPG) und receptor activator of NF-κB-ligand [NF-kappa-B-ligand] (RANKL) in der Schilddrüse
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Deutsch
- Anmerkungen
-
Marburg, Univ., Diss., 2005
- Schlagwort
-
Schilddrüse ; Basedow-Krankheit ; Autoaggressionskrankheit
Endokrinologie
- Urheber
-
Kluger, Sibylle
- URN
-
urn:nbn:de:hebis:04-z2005-07084
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Kluger, Sibylle
Ähnliche Objekte (12)
Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
Regulation von Osteoprotegerin (OPG) und receptor activator of nuclear factor-κB [factor-kappa-B] ligand (RANKL) in humanen Schilddrüsenkarzinomzellen
Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB
LMS-based continuous pediatric reference values for soluble receptor activator of nuclear factor kappa B ligand (sRANKL) and osteoprotegerin (OPG) in the HARP cohort
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
![Regulated gene over-expression of receptor activator of NF-κB [NF-kappa-B] ligand (RANKL) in a porcine animal model](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Regulated gene over-expression of receptor activator of NF-κB [NF-kappa-B] ligand (RANKL) in a porcine animal model
Auswirkung von Bisphosphonaten auf die Expression von Osteoprotegerin (OPG) und Receptor activator of nuclear factor kappa-B ligand (RANKL) in Osteoblastenkulturen aus Unterkiefer und Becken : eine Pilotstudie am Hausschwein
Regulated gene over-expression of Receptor Activator of NF-kappaB Ligand (RANKL) in a porcine animal model
Die Rolle von Receptor Activator of NF-kB (RANK) und Receptor Activator of NF-kB Ligand (RANKL) beim humanen Pankreaskarzinom in vitro
Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
RANK/RANKL/OPG system in the intervertebral disc
Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction
Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
Regulation von Osteoprotegerin (OPG) und receptor activator of nuclear factor-κB [factor-kappa-B] ligand (RANKL) in humanen Schilddrüsenkarzinomzellen
Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB
LMS-based continuous pediatric reference values for soluble receptor activator of nuclear factor kappa B ligand (sRANKL) and osteoprotegerin (OPG) in the HARP cohort
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
Regulated gene over-expression of receptor activator of NF-κB [NF-kappa-B] ligand (RANKL) in a porcine animal model
Auswirkung von Bisphosphonaten auf die Expression von Osteoprotegerin (OPG) und Receptor activator of nuclear factor kappa-B ligand (RANKL) in Osteoblastenkulturen aus Unterkiefer und Becken : eine Pilotstudie am Hausschwein
Regulated gene over-expression of Receptor Activator of NF-kappaB Ligand (RANKL) in a porcine animal model
Die Rolle von Receptor Activator of NF-kB (RANK) und Receptor Activator of NF-kB Ligand (RANKL) beim humanen Pankreaskarzinom in vitro
Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
RANK/RANKL/OPG system in the intervertebral disc
Selective inhibition of receptor activator of NF-κB ligand (RANKL) in hematopoietic cells improves outcome after experimental myocardial infarction
Serum proinflammatory cytokines, receptor activator of nuclear factor kappa-Β ligand (RANKL), osteoprotegerin (OPG) and RANKL/OPG ratio in mild and severe COVID-19
Regulation von Osteoprotegerin (OPG) und receptor activator of nuclear factor-κB [factor-kappa-B] ligand (RANKL) in humanen Schilddrüsenkarzinomzellen
Cucumber seed polypeptides regulate RANKL-induced osteoclastogenesis through OPG/RANKL/RANK and NF-κB
LMS-based continuous pediatric reference values for soluble receptor activator of nuclear factor kappa B ligand (sRANKL) and osteoprotegerin (OPG) in the HARP cohort
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
Regulated gene over-expression of receptor activator of NF-κB [NF-kappa-B] ligand (RANKL) in a porcine animal model
Auswirkung von Bisphosphonaten auf die Expression von Osteoprotegerin (OPG) und Receptor activator of nuclear factor kappa-B ligand (RANKL) in Osteoblastenkulturen aus Unterkiefer und Becken : eine Pilotstudie am Hausschwein
Regulated gene over-expression of Receptor Activator of NF-kappaB Ligand (RANKL) in a porcine animal model
Die Rolle von Receptor Activator of NF-kB (RANK) und Receptor Activator of NF-kB Ligand (RANKL) beim humanen Pankreaskarzinom in vitro
Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
RANK/RANKL/OPG system in the intervertebral disc